Thomas Stankovich is Chief Financial Officer of ReShape Lifesciences Inc.. Currently has a direct ownership of 22,777 shares of RSLS, which is worth approximately $130,967. The most recent transaction as insider was on Jun 01, 2022, when has been sold 4,478 shares (Common Stock, $0.001 par value per share) at a price of $0.96 per share, resulting in proceeds of $4,299. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.8K
0% 3M change
0.75% 12M change
Total Value Held $130,967

THOMAS STANKOVICH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2022
SELL
Open market or private sale
$4,299 $0.96 p/Share
4,478 Reduced 1.22%
361,149 Common Stock, $0.001 p...
May 31 2022
BUY
Open market or private purchase
$18,200 $0.91 p/Share
20,000 Added 5.19%
365,627 Common Stock, $0.001 p...
May 05 2022
SELL
Open market or private sale
$3,487 $0.77 p/Share
4,529 Reduced 1.29%
345,627 Common Stock, $0.001 p...
Apr 01 2022
SELL
Open market or private sale
$5,693 $1.13 p/Share
5,038 Reduced 1.42%
350,156 Common Stock, $0.001 p...
Feb 28 2022
SELL
Open market or private sale
$3,877 $1.06 p/Share
3,658 Reduced 1.02%
355,194 Common Stock, $0.001 p...
Jan 31 2022
SELL
Open market or private sale
$4,494 $1.22 p/Share
3,684 Reduced 1.02%
358,852 Common Stock, $0.001 p...
Jan 04 2022
SELL
Open market or private sale
$5,644 $1.78 p/Share
3,171 Reduced 0.87%
362,536 Common Stock, $0.001 p...
Dec 02 2021
SELL
Open market or private sale
$7,876 $1.83 p/Share
4,304 Reduced 1.16%
365,707 Common Stock, $0.001 p...
Nov 18 2021
BUY
Open market or private purchase
$40,400 $2.02 p/Share
20,000 Added 5.13%
370,011 Common Stock, $0.001 p...
Nov 02 2021
SELL
Open market or private sale
$11,621 $2.69 p/Share
4,320 Reduced 1.22%
350,011 Common Stock, $0.001 p...
Oct 01 2021
SELL
Open market or private sale
$10,102 $2.76 p/Share
3,660 Reduced 1.02%
354,331 Common Stock, $0.001 p...
Sep 10 2021
SELL
Open market or private sale
$139,778 $2.89 p/Share
48,366 Reduced 11.9%
357,991 Common Stock, $0.001 p...
Aug 30 2021
BUY
Open market or private purchase
$51,450 $3.43 p/Share
15,000 Added 31.5%
32,613 Common Stock, $0.001 p...
Aug 20 2021
BUY
Open market or private purchase
$48,300 $3.22 p/Share
15,000 Added 45.99%
17,613 Common Stock, $0.001 p...
Jul 22 2021
BUY
Grant, award, or other acquisition
-
372,744 Added 47.84%
406,357 Common Stock, $0.001 p...

Also insider at

RSLS
ReShape Weightloss Inc.
TS

Thomas Stankovich

Chief Financial Officer
San Clemente, CA

Track Institutional and Insider Activities on RSLS

Follow ReShape Lifesciences Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RSLS shares.

Notify only if

Insider Trading

Get notified when an Re Shape Lifesciences Inc. insider buys or sells RSLS shares.

Notify only if

News

Receive news related to ReShape Lifesciences Inc.

Track Activities on RSLS